Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Jerry S Wolinsky

The Efficacy of Teriflunomide in Patients Who Received Prior Disease-Modifying Treatments: Subgroup Analyses of the Teriflunomide Phase 3 TEMSO and TOWER Studies

Multiple Sclerosis

Neurology

2017

English

Related publications

Clinical Efficacy of Teriflunomide Over a Fixed 2-Year Duration in the TOWER Study

Multiple Sclerosis Journal - Experimental, Translational and Clinical

2018

English

Clinical Recommendations on the Use of Teriflunomide

Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova

English

Teriflunomide Treatment Reduces B Cells in Patients With MS

Neurology: Neuroimmunology and NeuroInflammation

Neurology

2017

English

Tolerability and Discontinuation Rates in Teriflunomide-Treated Patients. A Real-World Clinical Experience

English

Teriflunomide in the Treatment of Multiple Sclerosis: Current Evidence and Future Prospects

Therapeutic Advances in Neurological Disorders

Neurology

Pharmacology

2014

English

Efficacy and Safety of Sirukumab in Japanese Patients With Moderate to Severe Rheumatoid Arthritis Inadequately Controlled by Disease Modifying Anti-Rheumatic Drugs: Subgroup Analysis of a Phase 3 Study

English

Comparing Outcomes From Clinical Studies of Oral Disease-Modifying Therapies (Dimethyl Fumarate, Fingolimod, and Teriflunomide) in Relapsing MS: Assessing Absolute Differences Using a Number Needed to Treat Analysis

Multiple Sclerosis and Related Disorders

Medicine

Neurology

2016

English

Efficacy and Safety of Trabectedin or Dacarbazine for the Treatment of Patients With Uterine Leiomyosarcoma After Prior Chemotherapy: A Subgroup Analysis of the Randomized Phase 3 SAR-3007 Study

English

Pnd60 - Cost-Effectiveness of Teriflunomide for the Treatment of Relapsing-Remitting Multiple Sclerosis in Greece

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Jerry S Wolinsky

The Efficacy of Teriflunomide in Patients Who Received Prior Disease-Modifying Treatments: Subgroup Analyses of the Teriflunomide Phase 3 TEMSO and TOWER Studies

Related publications

Clinical Efficacy of Teriflunomide Over a Fixed 2-Year Duration in the TOWER Study

Clinical Recommendations on the Use of Teriflunomide

Teriflunomide Treatment Reduces B Cells in Patients With MS

Tolerability and Discontinuation Rates in Teriflunomide-Treated Patients. A Real-World Clinical Experience

Teriflunomide in the Treatment of Multiple Sclerosis: Current Evidence and Future Prospects

Efficacy and Safety of Sirukumab in Japanese Patients With Moderate to Severe Rheumatoid Arthritis Inadequately Controlled by Disease Modifying Anti-Rheumatic Drugs: Subgroup Analysis of a Phase 3 Study

Comparing Outcomes From Clinical Studies of Oral Disease-Modifying Therapies (Dimethyl Fumarate, Fingolimod, and Teriflunomide) in Relapsing MS: Assessing Absolute Differences Using a Number Needed to Treat Analysis

Efficacy and Safety of Trabectedin or Dacarbazine for the Treatment of Patients With Uterine Leiomyosarcoma After Prior Chemotherapy: A Subgroup Analysis of the Randomized Phase 3 SAR-3007 Study

Pnd60 - Cost-Effectiveness of Teriflunomide for the Treatment of Relapsing-Remitting Multiple Sclerosis in Greece